mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.0099 |
0.8 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.8 |
mRNA |
TAE684 |
GDSC1000 |
pan-cancer |
AAC |
0.015 |
0.8 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
-0.0095 |
0.8 |
mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0097 |
0.8 |